Flexion Therapeutics, Inc. Deferred Tax Assets, Net of Valuation Allowance
Flexion Therapeutics, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2021-03-10
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-10 |
| 2018-12-31 | $0.00 8-K · filed 2020-05-20 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-10 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-24 |